Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 0.1 | uM | 8 | 1250.00 | 622.75 | 2433.00 | 1673.00 | 1.4543 | 1.6008 |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1964.00 | 1673.00 | 1.1739 | 1.2381 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 1250.00 | 622.75 | 1988.00 | 1673.00 | 1.1883 | 1.2572 |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 2058.00 | 1673.00 | 1.2301 | 1.3127 | |
| BT-20 | Linsitinib | 0.01 | uM | 8 | 1250.00 | 622.75 | 1776.00 | 1673.00 | 1.0616 | 1.0856 |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 1250.00 | 622.75 | 643.00 | 1673.00 | 0.3843 | 0.0227 |
| BT-20 | Lapatinib | 0.01 | uM | 8 | 1250.00 | 622.75 | 1853.00 | 1673.00 | 1.1076 | 1.1486 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 1250.00 | 622.75 | 1930.00 | 1673.00 | 1.1536 | 1.2109 |
| BT-20 | 17-AAG | 0.31623 | uM | 8 | 1250.00 | 622.75 | 577.00 | 1673.00 | 0.3449 | -0.0521 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 1250.00 | 622.75 | 1938.00 | 1673.00 | 1.1584 | 1.2173 |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1946.00 | 1673.00 | 1.1632 | 1.2237 | |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 1250.00 | 622.75 | 1297.00 | 1673.00 | 0.7753 | 0.6730 |
| BT-20 | Lapatinib | 0.031623 | uM | 8 | 1250.00 | 622.75 | 1886.00 | 1673.00 | 1.1273 | 1.1754 |
| BT-20 | Lapatinib | 0.0016596 | uM | 8 | 1250.00 | 622.75 | 1832.00 | 1673.00 | 1.0950 | 1.1315 |
| BT-20 | 17-AAG | 0.031623 | uM | 8 | 1250.00 | 622.75 | 567.00 | 1673.00 | 0.3389 | -0.0637 |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1509.00 | 1673.00 | 0.9020 | 0.8604 | |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1582.00 | 1673.00 | 0.9456 | 0.9231 | |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3415.00 | 3879.25 | 0.8803 | 0.8400 | |
| BT-20 | 0 | uM | 8 | 2500.00 | 1344.63 | 3465.00 | 3879.25 | 0.8932 | 0.8576 | |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 2500.00 | 1344.63 | 3617.00 | 3879.25 | 0.9324 | 0.9105 |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 2500.00 | 1344.63 | 3800.00 | 3879.25 | 0.9796 | 0.9732 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 2500.00 | 1344.63 | 3826.00 | 3879.25 | 0.9863 | 0.9820 |
| BT-20 | Erlotinib | 1 | uM | 8 | 2500.00 | 1344.63 | 3502.00 | 3879.25 | 0.9028 | 0.8705 |
| BT-20 | Lapatinib | 10 | uM | 8 | 2500.00 | 1344.63 | 2191.00 | 3879.25 | 0.5648 | 0.3763 |
| BT-20 | Linsitinib | 0.031623 | uM | 8 | 2500.00 | 1344.63 | 3996.00 | 3879.25 | 1.0301 | 1.0392 |